Found: 5
Select item for more details and to access through your institution.
Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 937, doi. 10.4143/crt.2016.423
- By:
- Publication type:
- Article
Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR-Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE).
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 9, p. 539, doi. 10.1159/000448085
- By:
- Publication type:
- Article
Dose Intensity Phase l/lI Trial with Carboplatin, Ifosfamide, Etoposide and Vincristine Combined with Filgrastim in Patients with Small-Cell Lung Cancer.
- Published in:
- Oncology, 1997, v. 54, n. 5, p. 363, doi. 10.1159/000227719
- By:
- Publication type:
- Article